HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Huimian Xu Selected Research

Carcinogenesis

7/2015Novel long non-coding RNA RP11-119F7.4 as a potential biomarker for the development and progression of gastric cancer.
11/2014The novel long noncoding RNA AC138128.1 may be a predictive biomarker in gastric cancer.
1/2013Expression of legumain correlates with prognosis and metastasis in gastric carcinoma.
9/2012MicroRNA-148b suppresses cell growth by targeting cholecystokinin-2 receptor in colorectal cancer.
5/2012Expression levels of microRNA-375 in colorectal carcinoma.
3/2012microRNA-192, -194 and -215 are frequently downregulated in colorectal cancer.
7/2010Altered expression of MiR-148a and MiR-152 in gastrointestinal cancers and its clinical significance.
8/2007Paradoxical expression of maspin in gastric carcinomas: correlation with carcinogenesis and progression.
1/2005Interleukin-8, cyclo-oxygenase-2, and trefoil factor family 1 gene expression and their association with Helicobacter pylori infection in the remnant stomach.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Huimian Xu Research Topics

Disease

63Stomach Neoplasms (Stomach Cancer)
10/2023 - 05/2005
49Neoplasms (Cancer)
01/2022 - 02/2005
17Neoplasm Metastasis (Metastasis)
10/2022 - 02/2005
14Lymphatic Metastasis
01/2022 - 02/2005
11Colorectal Neoplasms (Colorectal Cancer)
10/2023 - 07/2010
9Carcinogenesis
07/2015 - 01/2005
8Carcinoma (Carcinomatosis)
02/2014 - 02/2005
5Breast Neoplasms (Breast Cancer)
01/2017 - 03/2010
3Adenocarcinoma
01/2021 - 12/2012
3Colonic Neoplasms (Colon Cancer)
01/2020 - 09/2012
2Microsatellite Instability
10/2022 - 01/2022
2Gastrointestinal Neoplasms (Gastrointestinal Cancer)
01/2014 - 07/2010
2Inflammation (Inflammations)
07/2010 - 01/2005
1Wounds and Injuries (Trauma)
10/2022
1Margins of Excision
08/2020
1Lung Neoplasms (Lung Cancer)
01/2020
1Osteosarcoma (Osteogenic Sarcoma)
05/2017
1Esophageal Neoplasms (Esophageal Cancer)
02/2017
1Embolism (Embolus)
02/2017
1Circulating Neoplastic Cells
12/2014
1Vomiting
11/2014
1Nausea
11/2014
1Leukemia
05/2014

Drug/Important Bio-Agent (IBA)

13Biomarkers (Surrogate Marker)IBA
11/2020 - 01/2005
11Proteins (Proteins, Gene)FDA Link
01/2022 - 07/2010
7RNA (Ribonucleic Acid)IBA
01/2023 - 07/2010
7MicroRNAs (MicroRNA)IBA
09/2017 - 07/2010
4Long Noncoding RNAIBA
01/2018 - 11/2014
4Small Interfering RNA (siRNA)IBA
02/2014 - 09/2012
4Phosphotransferases (Kinase)IBA
06/2011 - 07/2010
3Immune Checkpoint InhibitorsIBA
10/2022 - 02/2021
3EnzymesIBA
04/2021 - 03/2011
3Messenger RNA (mRNA)IBA
08/2016 - 05/2005
3Oncogene Proteins (Oncogene Protein)IBA
08/2016 - 09/2013
3Therapeutic UsesIBA
02/2014 - 03/2011
3heparanaseIBA
07/2010 - 02/2005
2human ERBB2 proteinIBA
01/2022 - 03/2010
2Fluorouracil (Carac)FDA LinkGeneric
01/2021 - 11/2014
2Capecitabine (Xeloda)FDA Link
01/2021 - 04/2015
2Paclitaxel (Taxol)FDA LinkGeneric
03/2019 - 11/2014
2Estrogen ReceptorsIBA
01/2017 - 03/2010
2Proliferating Cell Nuclear Antigen (PCNA)IBA
01/2017 - 05/2014
2Transcription Factor 3IBA
05/2014 - 12/2012
2DNA (Deoxyribonucleic Acid)IBA
05/2014 - 01/2014
2Formaldehyde (Formol)FDA Link
07/2013 - 03/2013
2ParaffinIBA
07/2013 - 03/2013
2Cyclin D1IBA
12/2012 - 09/2012
2Cholecystokinin B ReceptorIBA
09/2012 - 07/2010
2NestinIBA
06/2011 - 03/2010
2NucleosidesIBA
06/2011 - 07/2010
2Progesterone Receptors (Progesterone Receptor)IBA
09/2010 - 03/2010
1ElementsIBA
01/2022
1Transforming Growth Factor beta (TGF-beta)IBA
04/2021
1CytokinesIBA
04/2021
1ImmunosorbentsIBA
04/2021
1B7-H1 AntigenIBA
02/2021
1CTLA-4 AntigenIBA
02/2021
1Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2021
1Extracellular Matrix ProteinsIBA
01/2021
1nephronectinIBA
11/2020
1Indicators and Reagents (Reagents)IBA
08/2020
1UbiquitinsIBA
08/2020
1LectinsIBA
01/2020
1N-(4-isothiocyanatophenethyl)spiperoneIBA
01/2020
1CalciumIBA
01/2020
1p21-Activated KinasesIBA
09/2017
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
05/2017
1ORALIT (ORS)IBA
01/2017
1ErbB Receptors (EGF Receptor)IBA
04/2015
1mesoglycanIBA
11/2014
1N-acetyltalosaminuronic acid (NAT)IBA
11/2014
1Transforming Growth Factors (Transforming Growth Factor)IBA
07/2014
1Activins (Activin)IBA
07/2014
1Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
07/2014
1Transcription Factors (Transcription Factor)IBA
05/2014
1SurvivinIBA
02/2014
1Vascular Endothelial Growth Factor CIBA
02/2014
1Fetal Proteins (Fetoprotein)IBA
02/2014
1Lactate Dehydrogenase 5IBA
01/2014
1hydrogen sulfite (bisulfite)IBA
01/2014
1DecitabineFDA Link
01/2014
1Lactic Acid (Lactate)FDA LinkGeneric
01/2014
1Pyruvic Acid (Pyruvate)IBA
01/2014
1Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA
09/2013

Therapy/Procedure

23Gastrectomy
01/2021 - 01/2005
14Drug Therapy (Chemotherapy)
10/2022 - 06/2011
7Therapeutics
10/2022 - 12/2010
6Adjuvant Chemotherapy
10/2022 - 12/2008
6Lymph Node Excision (Lymph Node Dissection)
01/2021 - 02/2005
4Chemoradiotherapy
10/2022 - 01/2020
3Lasers (Laser)
11/2014 - 02/2005
2Immunotherapy
07/2023 - 10/2022
2Radiotherapy
10/2022 - 01/2021
2Aftercare (After-Treatment)
01/2014 - 04/2009
2Mastectomy (Mammectomy)
09/2010 - 03/2010
1Blood Transfusion (Blood Transfusions)
10/2023
1Anesthesia
10/2022
1Molecular Targeted Therapy
01/2022
1Precision Medicine
01/2022
1Metastasectomy
01/2019